Hana Pharm Co Ltd (293480) — Cash Flow Reinvestment Rate
Hana Pharm Co Ltd (293480) has a Cash Flow Reinvestment Rate of 45.12x as of June 2025, reinvesting ₩10.61 Billion (capex ₩10.01 Billion plus investments ₩-600.00 Million) from operating cash flow of ₩235.15 Million. See Hana Pharm Co Ltd (293480) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hana Pharm Co Ltd Cash Flow Reinvestment Rate (2016–2024)
Historical reinvestment intensity for Hana Pharm Co Ltd across 9 annual periods. For the full cash flow conversion analysis, see Hana Pharm Co Ltd cash flow conversion.
Annual Cash Flow Reinvestment Rate for Hana Pharm Co Ltd (2016–2024)
Year-by-year capital reinvestment analysis for Hana Pharm Co Ltd. See Hana Pharm Co Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.57x | ₩14.30 Billion | ₩25.30 Billion | ₩13.21 Billion | ▼ -60.9% |
| 2023 | 1.44x | ₩26.58 Billion | ₩18.40 Billion | ₩14.68 Billion | ▼ -38.3% |
| 2022 | 2.34x | ₩72.28 Billion | ₩30.88 Billion | ₩35.77 Billion | ▼ -14.6% |
| 2021 | 2.74x | ₩70.31 Billion | ₩25.66 Billion | ₩34.81 Billion | ▲ +137.4% |
| 2020 | 1.15x | ₩17.98 Billion | ₩15.58 Billion | ₩17.14 Billion | ▼ -30.7% |
| 2019 | 1.66x | ₩52.79 Billion | ₩31.72 Billion | ₩33.73 Billion | ▼ -55.6% |
| 2018 | 3.75x | ₩103.50 Billion | ₩27.59 Billion | ₩5.57 Billion | ▲ +691.2% |
| 2017 | 0.47x | ₩12.04 Billion | ₩25.38 Billion | ₩10.19 Billion | ▼ -36.3% |
| 2016 | 0.74x | ₩9.27 Billion | ₩12.46 Billion | ₩8.31 Billion | — |